General Proximity is a biotechnology company pioneering next-generation "proximity medicines" that control biological processes by inducing proximity between molecular targets. Its multi-target OMNITAC platform is used to discover and advance novel therapeutics, including an oncology collaboration with Daiichi Sankyo. - View it on GitHub